Menu

Blog

Dec 16, 2021

Rejuveron funds $29 million for degenerative eye disease

Posted by in category: biotech/medical

Rejuveron increases to near-majority stake in Endogena to progress treatments for degenerative diseases of the eye.

Leave a reply